KPVPrescription KPV
When your gut will not settle down.
KPV is a three-amino-acid peptide studied in intestinal cells and mouse colitis models. The studies measured quieter inflammatory signaling and less damage in colon tissue.
Why KPV gets attention
A tiny fragment with a direct line into gut-inflammation studies.
KPV is lysine-proline-valine—the C-terminal fragment of α-MSH. Its size matters in the published work: PepT1 transported the tripeptide into intestinal epithelial and immune cells, where two major inflammatory signal networks were measured lower.
The plans your gut interrupts still count.The day-to-day problem
When a touchy gut turns ordinary plans into calculations.
Meals, travel, training, and sleep can all start revolving around whether your gut will cooperate. KPV gets attention because its published evidence sits close to intestinal transport and inflammatory signaling.
The published work follows intestinal-cell transport and signaling, then weight recovery, MPO activity, and colon histology in mouse colitis models.
The KPV vial
KPV injection, in one 20-day vial.
The planned product is a 10 mg injection in a 5 mL vial. A licensed U.S. compounding pharmacy would dispense it, and the patient-specific label identifies the formulation, strength, storage, and beyond-use date.
- Active
- KPV
- Strength
- 10 mg
- Package
- 5 mL vial
- Planned supply
- 20 days
For Rebody members